N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model (Q80263042)

From Wikidata

Jump to navigation Jump to search

scientific article published on 04 August 2006

Language	Label	Description	Also known as
English	N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model	scientific article published on 04 August 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

based on heuristic

inferred from title

6

object named as

Anke Huckriede

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

8

object named as

Wim Jiskoot

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Maryam Amidi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Stefan G Romeijn

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

J Coos Verhoef

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Hans E Junginger

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Laura Bungener

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Daan J A Crommelin

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

4 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

144-153

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

IgG2a restriction of murine antibodies elicited by viral infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

The immunoglobulin G subclass responses of mice to influenza A virus: the effect of mouse strain, and the neutralizing abilities of individual protein A-purified subclass antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

The IgG subclass responses to influenza virus haemagglutinin in the mouse: effect of route of inoculation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Immunity to influenza in man

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Immunoglobulin A: strategic defense initiative at the mucosal surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Nasal delivery of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Chitosan as a novel nasal delivery system for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

The role of nasopharyngeal lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

NALT- versus Peyer's-patch-mediated mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Evaluation of the clearance characteristics of bioadhesive systems in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Clearance characteristics of chitosan based formulations in the sheep nasal cavity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Nasal drug delivery--possibilities, problems and solutions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

A novel bioadhesive intranasal delivery system for inactivated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Potential of polymer microencapsulation technology for vaccine innovation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Aspects of the design and delivery of microparticles for vaccine applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Chitosan and its use as a pharmaceutical excipient

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Chitosan: a unique polysaccharide for drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Chitosan as a novel nasal delivery system for peptide drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Blood compatibility and biodegradability of partially N-acylated chitosan derivatives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Human enzymatic activities related to the therapeutic administration of chitin derivatives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Chitosan--as a biomaterial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Large molecule and particulate uptake in the nasal cavity: the effect of size on nasal absorption

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Transport of nanoparticles across the rat nasal mucosa.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Microsphere absorption by the nasal mucosa of the rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Lung dendritic cells are primed by inhaled particulate antigens, and retain MHC class II/antigenic peptide complexes in hilar lymph nodes for a prolonged period of time

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

N-trimethyl chitosan chloride: optimum degree of quaternization for drug absorption enhancement across epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Evaluation of the mucoadhesive properties of N-trimethyl chitosan chloride

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Bronchus- and nasal-associated lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

Secretory anti-influenza immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.086

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.06.086

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16973248%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80263042&oldid=1766091874"